Xellia Pharma completes $13 million Hungarian plant expansion

22 August 2017
drugs_pills_tablets_big

Danish specialty pharma firm  Xellia Pharmaceuticals has completed the expansion of its new $13 million, Centralized Laboratory Services building at its Budapest, Hungary, manufacturing site.

The expansion strengthens the global anti-infective product capabilities with additional product stability and release testing expertise and capabilities, of Xellia, a Novo Group company.

The new 3,000m2, multi-story building accommodates state-of-the-art microbiology and chemical analytical laboratories, a product stability center and administrative offices. It is conveniently located next to Xellia’s current active pharmaceutical ingredient (APIs) manufacturing plant, which employs 250 people.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Generics